Nektar Therapeutics Reports Third Quarter 2023 Financial Res

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2023. Cash and investments in...

Related Keywords

Alabama , United States , San Francisco , California , Vivian Wu , David Rosen , Cellular Biomedicine Group Inc , Cellular Biomedicine Group , Nektar Therapeutics , European Academy Of Dermatology , Exchange Commission On , Duke Cancer Institute , Recent Business , Duke Cancer , Eczema Area , Severity Index , Validated Investigator Global Assessment , Body Surface Area , Itch Numeric Rating Scale , Daily Life Quality Index , Patient Oriented Eczema Measure , Discuss Third Quarter , Home Page , Nektar Earnings Call , Annual Report , Exchange Commission ,